Trial intelligence / Profile preview

PICASSO-IMT: Cilostazol and Probucol in Ischemic Stroke

NCT02483169Phase 4Unknown

Sponsor
Asan Medical Center
Start
Jun 2009
Primary completion
Sep 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of cilostazol, probucol in ischemic stroke, atherosclerosis, sponsored by Asan Medical Center. Status: unknown.

02

Drugs

cilostazolprobucol
03

Conditions

ischemic strokeatherosclerosis

Beyond the preview

Go deeper on NCT02483169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02483169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call